Download PDF
Vet Comp Orthop Traumatol 2013; 26(06): VII-VIII
DOI: 10.3415/VCOT-13-10-0125
Guest Editorial
Schattauer GmbH

Out-Sourcing Stem Cells for Clinical Applications

Further Information

Publication History

Publication Date:
04 January 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Pigott JH, Ishihara A, Wellman ML. et al. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses. Vet Comp Orthop Traumatol 2013; 26: 453-460.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Gafni Y, Turgeman G, Liebergal M. et al. Stem cells as vehicles for orthopedic gene therapy. Gene Ther 2004; 11: 417-426.
    CrossrefPubMedGoogle Scholar
  • 3 Grande DA, Mason J, Light E. et al. Stem cells as platforms for delivery of genes to enhance cartilage repair. J Bone Joint Surg Am 2003; 85 (Suppl 2) 111-116.
    PubMedGoogle Scholar
  • 4 Park J, Gelse K, Frank S. et al. Transgene-activated mesenchymal stem cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/ periosteum- and fat-derived cells. J Gene Med 2006; 8: 112-125.
    CrossrefPubMedGoogle Scholar
  • 5 Agung M, Ochi M, Yanada S. et al. Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc 2006; 14: 1307-1314.
    CrossrefPubMedGoogle Scholar
  • 6 Jing XH, Yang L, Duan XJ. et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine 2008; 75: 432-438.
    CrossrefPubMedGoogle Scholar
  • 7 Murphy JM, Fink DJ, Hunziker EB. et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48: 3464-3474.
    CrossrefPubMedGoogle Scholar
  • 8 Watts AE, Nixon AJ. Distribution and homing of stem cells after intra-articular injection to normal and arthritic joints. Proceedings of the 2011 ACVS Veterinary Symposium. 2011. November 3-5 Chicago, IL, USA: 40 E50.
    Google Scholar
  • 9 González MA, González-Rey E, Rico L. et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009; 60: 1006-1019.
    CrossrefPubMedGoogle Scholar
  • 10 Zheng ZH, Li XY, Ding J. et al. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology 2008; 47: 22-30.
    CrossrefPubMedGoogle Scholar
  • 11 Augello A, Tasso R, Negrini SM. et al. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007; 56: 1175-1186.
    CrossrefPubMedGoogle Scholar
  • 12 Lozito TP, Tuan RS. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol 2011; 226: 385-396.
    CrossrefPubMedGoogle Scholar
  • 13 Toghraie FS, Chenari N, Gholipour MA. et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee 2011; 18: 71-75.
    CrossrefPubMedGoogle Scholar
  • 14 Grigolo B, Lisignoli G, Desando G. et al. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng Part C Methods 2009; 15: 647-658.
    CrossrefPubMedGoogle Scholar
  • 15 Frisbie DD, Kisiday JD, Kawcak CE. et al. Evaluation of adipose derived stromal vascular fraction or bone marrow derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009; 27: 1675-1680.
    CrossrefPubMedGoogle Scholar
  • 16 McIlwraith CW, Frisbie DD, Rodkey WG. et al. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy 2011; 27: 1152-1161.
    PubMedGoogle Scholar
  • 17 Ferris DJ, Frisbie DD, Kisiday JD. et al. Clinical follow-up of horses treated with bone marrow derived mesenchymal stem cells for musculoskeletal lesions. Proceedings of the 55th Annual Convention of the American Association of Equine Practitioners. 2009. December 5-9 Las Vegas, Nevada, USA: 55 59-60.
    Google Scholar
  • 18 Walmsley JP, Phillips TJ, Townsend HG. Meniscal tears in horses: an evaluation of clinical signs and arthroscopic treatment of 80 cases. Equine Vet J 2003; 35: 402-406.
    PubMedGoogle Scholar
  • 19 Cohen JM, Richardson DW, McKnight AL. et al. Long-term outcome in 44 horses with stifle lameness after arthroscopic exploration and debridement. Vet Surg 2009; 38: 543-551.
    CrossrefPubMedGoogle Scholar
  • 20 Murphy MJ, Dixon K, Beck S. et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002; 46: 704-713.
    CrossrefPubMedGoogle Scholar
  • 21 Kiefer K, Conzemius MG, Pluhar GE. Canine adipose derived stem cell viability following exposure to synovial fluid from osteoarthritic joints. Vet Comp Orthop Traumatol. 2013 26. A7.
    PubMedGoogle Scholar